Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Vaccines

Free Subscription 01.06.2026 1 AIDS 1 BMJ 3 J Infect 1 J Infect Dis 1 J Virol 2 Nat Immunol 1 PLoS Comput Biol 7 PLoS One 29 Vaccine 2 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. RYSCAVAGE P, Knable C, Taylor G
   Low measles seroprotection among adults with perinatally acquired HIV.
   AIDS. 2026;40:1041-1043.
   PubMed         Abstract available
   
   

   
   BMJ

2. DOYON-PLOURDE P, Abrams EM, Pless R, Tunis M, et al
   The story of aluminium containing vaccines is bigger than any one study.
   BMJ. 2026;393:e993389.
   PubMed        
   
   

   
   J Infect

3. WANG X, He L, Li Y, Meng Q, et al
   Pertactin expression in Chinese Bordetella pertussis: A Critical Reappraisal of PRN inclusion in pertussis vaccines.
   J Infect. 2026 May 28:106777. doi: 10.1016/j.jinf.2026.106777.
   PubMed        
   
   
4. WEE LE, Ho RWL, Lim JT, Lim SK, et al
   Real-world effectiveness of influenza vaccination amongst children aged under 5 in a tropical setting.
   J Infect. 2026 May 26:106771. doi: 10.1016/j.jinf.2026.106771.
   PubMed         Abstract available
   
   
5. CORRAO G, Sguazzini E, Gori A, Monti E, et al
   All-cause mortality within seven days of COVID-19 vaccination: A matched cohort and self-controlled case series study in Lombardy, Italy.
   J Infect. 2026;93:106769.
   PubMed         Abstract available
   
   

   
   J Infect Dis

6. RODRIGUEZ-MOLINO P, Rodriguez Galet A, Falces-Romero I, Alcolea S, et al
   Vaccine Response Assessment in Children Using Dried Blood Spots: The DRIVE Study.
   J Infect Dis. 2026 May 26:jiag274. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

7. LOES AN, Tarabi RAL, Li SH, Atkinson RK, et al
   Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccines.
   J Virol. 2026 May 27:e0031726. doi: 10.1128/jvi.00317.
   PubMed         Abstract available
   
   

   
   Nat Immunol

8. 
   Fungal glycans boost mRNA-based vaccines.
   Nat Immunol. 2026 May 25. doi: 10.1038/s41590-026-02522.
   PubMed        
   
   
9. JENA KK, Qu P, Baracco L, Saghaei S, et al
   A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines.
   Nat Immunol. 2026 May 22. doi: 10.1038/s41590-026-02517.
   PubMed         Abstract available
   
   

   
   PLoS Comput Biol

10. KWON J, Li K, Warren JL, Pandya S, et al
    Utilizing virus genomic surveillance to predict vaccine effectiveness.
    PLoS Comput Biol. 2026;22:e1014329.
    PubMed         Abstract available
    
    

    
    PLoS One

11. RODRIGUEZ-BLANCO N, Vicente-Alcalde N, Orts-Ruiz C, Montero-Navarro S, et al
    Knowledge gaps and positive attitudes toward adult vaccination among nursing students: A Cross-sectional study.
    PLoS One. 2026;21:e0350295.
    PubMed         Abstract available
    
    
12. WARNE DJ, Varghese A, Brewster A, Browning AP, et al
    Bayesian uncertainty quantification to identify population level vaccine hesitancy behaviours.
    PLoS One. 2026;21:e0349499.
    PubMed         Abstract available
    
    
13. WASEEM M, Kamran Z, Ali A
    Advancing poultry health: A meta-analysis of epitope-based and peptide-based vaccines against Avian Pathogenic E. coli with machine learning insights.
    PLoS One. 2026;21:e0349094.
    PubMed         Abstract available
    
    
14. MASUM MHU, Heema HP, Mahdeen AA, Lokman SM, et al
    System immunoinformatics-based design of a multi-epitope vaccine candidate against La Crosse virus.
    PLoS One. 2026;21:e0350287.
    PubMed         Abstract available
    
    
15. FIORE E, Taio G, Morandi N, Mazzotta E, et al
    Lung ultrasonography to assess efficacy of intranasal and parenteral vaccinations for bovine respiratory disease (BRD) in dairy calves.
    PLoS One. 2026;21:e0349953.
    PubMed         Abstract available
    
    
16. ZHAO M, Lei J, Feng Q, Lai S, et al
    Knowledge of HPV and HPV vaccine and its association with vaccination willingness among female undergraduates: A comparative cross-sectional study between healthcare and non-healthcare majors in Chengdu, China.
    PLoS One. 2026;21:e0349013.
    PubMed         Abstract available
    
    
17. WYPLOSZ B, Grenier B, Roche N, Roubille F, et al
    Correction: Pneumococcal vaccination at 65 years and vaccination coverage in at-risk adults: A retrospective population-based study in France.
    PLoS One. 2026;21:e0350226.
    PubMed         Abstract available
    
    

    
    Vaccine

18. MATHUR V, Schue JL, Fesshaye B, Singh P, et al
    Prevalence and determinants of fully vaccinated status for COVID-19 among pregnant women in Brazil, Ghana, Kenya, and Pakistan.
    Vaccine. 2026 May 29:128708. doi: 10.1016/j.vaccine.2026.128708.
    PubMed         Abstract available
    
    
19. QI X, Smolders C
    From COVAX deliveries to vaccination uptake in LMICs: a monthly panel analysis.
    Vaccine. 2026;86:128763.
    PubMed         Abstract available
    
    
20. SANDERSON K, Butt S, Campbell CNJ, Beck CR, et al
    Interventions to improve pre-school vaccination timeliness: a systematic review.
    Vaccine. 2026;87:128751.
    PubMed         Abstract available
    
    
21. SONG L, He G, Cui Y, Tan R, et al
    Optimized flagellin enhances systemic and mucosal immune responses induced by SARS-CoV-2 virus-like particle vaccines.
    Vaccine. 2026;87:128767.
    PubMed         Abstract available
    
    
22. SUN Y, Keskinocak P, Peak CM, Steimle LN, et al
    Global cessation of bivalent oral polio vaccine (bOPV): A comprehensive review of modeling studies from 2000 to 2025.
    Vaccine. 2026;86:128707.
    PubMed         Abstract available
    
    
23. CASSIMOS DC, Effraimidou E, Irakleidou I, Medic S, et al
    Vaccine-preventable disease outbreaks in schools, part 2: pertussis, meningococcal disease, diphtheria, poliomyelitis, hepatitis A, and rotavirus infection.
    Vaccine. 2026;86:128750.
    PubMed         Abstract available
    
    
24. JUFUKU R, Shinchi H, Murata K, Chan M, et al
    TLR7 ligand-cyclodextrin conjugate is a promising adjuvant for intranasal influenza vaccine.
    Vaccine. 2026;86:128762.
    PubMed         Abstract available
    
    
25. SURAPANENI S, Baxter Z, Abdurrob A, Leonard K, et al
    Using non-primary care clinical settings to increase HPV vaccination uptake: a scoping review.
    Vaccine. 2026;86:128759.
    PubMed         Abstract available
    
    
26. JANECZKO M, Kubinski K, Wawiorka L
    Antifungal vaccine development: where we are, where we are headed.
    Vaccine. 2026;86:128766.
    PubMed         Abstract available
    
    
27. CHOU S, Boman CD
    Increasing prebunking effectiveness to aid disinformation-susceptible publics in overcoming vaccine-related disinformation.
    Vaccine. 2026;86:128749.
    PubMed         Abstract available
    
    
28. SHEN YS, Fang CY, Chan TT, Wu SR, et al
    Propagation and immunological characterization of three enterovirus D68 strains using serum-free HEK293A suspension cell culture.
    Vaccine. 2026;84:128665.
    PubMed         Abstract available
    
    
29. LI W, Li YA, Liu X, Xie H, et al
    Oral immunization with attenuated Salmonella enterica serovar Enteritidis expressing dual-toxin antigen induces protective immunity against avian necrotic enteritis.
    Vaccine. 2026;84:128684.
    PubMed         Abstract available
    
    
30. CARLOCK MA, Ross TM
    Retooling a novel influenza B hemagglutinin to redirect neutralizing antibodies against B/Victoria strains.
    Vaccine. 2026;84:128674.
    PubMed         Abstract available
    
    
31. MYBURGH L, van Loon K, Koetsier J, Hansen Q, et al
    Conjugate vaccine technology enhances responses to influenza virus.
    Vaccine. 2026;86:128728.
    PubMed         Abstract available
    
    
32. LIU R, Fan Y, Xiong S, Lin J, et al
    Drivers of and implementation strategies for influenza vaccination for cardiovascular populations in China: a scoping review.
    Vaccine. 2026;86:128761.
    PubMed         Abstract available
    
    
33. LI W, Liu S, Cui W, Tang S, et al
    A novel ferritin-based nanoparticle vaccine targeting lgE confers protection against chronic allergic asthma in a murine model.
    Vaccine. 2026;86:128754.
    PubMed         Abstract available
    
    
34. NDJEKA N, Subrayen P, Hanekom WA, Jassat W, et al
    Advancing national preparedness for the introduction of novel tuberculosis vaccines in South Africa: policy, evidence, and system readiness insights from a national workshop.
    Vaccine. 2026;86:128755.
    PubMed         Abstract available
    
    
35. MELN I, Van Molle W, Velez MP, Baay M, et al
    Second regulatory workshop on utilising in silico models to expedite vaccine development, testing, and lifecycle management - an expert meeting report.
    Vaccine. 2026;86:128733.
    PubMed         Abstract available
    
    
36. PERRY BRYCE NV, Marrero Arocho ML, Seybold D, Calhoun B, et al
    Improving Tdap vaccine uptake during pregnancy: a five-year analysis at a regional center.
    Vaccine. 2026 May 23:128709. doi: 10.1016/j.vaccine.2026.128709.
    PubMed         Abstract available
    
    
37. OKUBO Y, Honjyo R, Uda K, Miyairi I, et al
    Nationwide survey for household preparedness and vaccination acceptance during a novel influenza pandemic scenario in Japan, 2025.
    Vaccine. 2026;86:128738.
    PubMed         Abstract available
    
    
38. MACLENNAN CA, Davis P, Gottlieb SL, Seib KL, et al
    Consultation report - gonococcal immunoassays and standards for vaccine development.
    Vaccine. 2026;86:128694.
    PubMed         Abstract available
    
    
39. PAREKH K, Paton DJ, Browning C, Wilsden G, et al
    Preparing for exotic foot-and-mouth disease virus outbreaks in the European neighbourhood: cross-neutralisation of internationally available vaccines against South American serotype O and serotype A field isolates.
    Vaccine. 2026;86:128718.
    PubMed         Abstract available
    
    
40. GIANNINI F, Hogan AB, Blyth CC, Glass K, et al
    Modelling the impact of long-acting monoclonal antibody, maternal vaccine and hybrid programs of RSV immunisation in temperate Western Australia.
    Vaccine. 2026;86:128731.
    PubMed         Abstract available
    
    
41. ROCUSKIE-MARKER CM, Huckaby AB, Conaway OM, Pyles GM, et al
    Evaluation of EcoCRM, virus-like particles, and mRNA as vaccine platforms against Borrelia burgdorferi.
    Vaccine. 2026;86:128696.
    PubMed         Abstract available
    
    
42. CHAWANPAIBOON S, Anuwutnavin S, Kanjanapongporn A, Pooliam J, et al
    Corrigendum to "Breastfeeding women's attitudes towards and acceptance and rejection of COVID-19 vaccination: Implementation research" [Vaccine 41 (2023) 1198-1208].
    Vaccine. 2026;86:128752.
    PubMed        
    
    
43. FAIJUE DD, Bouaddi O, Segui AO, Morias B, et al
    Catch-up and life-course vaccination policies for adult and adolescent migrants in low-and-middle income countries: A policy analysis.
    Vaccine. 2026;85:128645.
    PubMed         Abstract available
    
    
44. MATHEBULA L, Wiysonge CS, Zunza M
    Childhood vaccination uptake and associated determinants among caregivers of young children in Cape Town, South Africa.
    Vaccine. 2026;86:128730.
    PubMed         Abstract available
    
    
45. COUNOUPAS C, Nisa A, Baker L, Pinto R, et al
    Targeted delivery of the BCG vaccine to dendritic cells improves protective efficacy against Mycobacterium tuberculosis.
    Vaccine. 2026;86:128753.
    PubMed         Abstract available
    
    
46. KATANA EB, Kiiza D, Odongpiny EAL, Simbwa BN, et al
    Willingness to receive Ebola vaccines among pregnant and lactating women in Kampala, Uganda: insights from a post-outbreak cross-sectional study.
    Vaccine. 2026;86:128737.
    PubMed         Abstract available
    
    

    
    Virology

47. ZIMINA A, Viktorova EG, Kouiavskaia D, Chumakov K, et al
    Towards the development of a mucosal vectored vaccine against enterovirus D68.
    Virology. 2026;621:110960.
    PubMed         Abstract available
    
    
48. MEIRHAEGHE MR, Balfour HH Jr
    The rationale for universal use of a prophylactic Epstein-Barr virus vaccine.
    Virology. 2026;622:110970.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum